2025-04-02 - Analysis Report
## Procter & Gamble Co. (PG) Stock Review

**0. Summary of Key Figures:**

* **Cumulative Return (PG):** 93.14%
* **Cumulative Return (VOO):** 89.44%
* **Return Difference:** 3.70%
* **Relative Divergence:** 32.6% (Indicates PG's performance is relatively higher than VOO considering historical volatility)
* **Market Risk Indicator (MRI):** 0.44 (Low to Medium Risk)
* **Expected Return (vs. S&P 500, long-term):** 38.4%


**1. Performance Comparison & Alpha/Beta Analysis:**

Procter & Gamble Co. (PG) is a multinational consumer goods corporation that manufactures and markets a wide variety of products.

PG significantly outperformed the S&P 500 (VOO) over the analyzed period, with a cumulative return of 93.14% compared to VOO's 89.44%.  The 3.7% difference, while seemingly small, represents a relatively high position (32.6%) within the historical range of performance differences between PG and VOO.

The provided alpha and beta analysis shows that PG consistently exhibits a positive alpha, indicating outperformance relative to the market (beta), particularly from 2017 to 2021.  While beta fluctuates, suggesting varying levels of market sensitivity across different periods, PG generally maintains a beta above 0, indicating a positive correlation with overall market movements.  The substantial increase in market capitalization (Cap(B)) reflects PG's growth over the years.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 16.0% | 5.0% | -2.0% | 0.1 | 177.8 |
| 2016-2018  | 10.0% | 9.1% | 3.0% | 0.0 | 184.2 |
| 2017-2019  | 46.0% | 9.1% | 27.0% | 0.2 | 257.3 |
| 2018-2020  | 64.0% | 9.1% | 30.0% | 0.1 | 293.7 |
| 2019-2021  | 67.0% | 9.1% | -6.0% | 0.1 | 353.9 |
| 2020-2022  | 25.0% | 67.6% | 14.0% | 0.1 | 336.1 |
| 2021-2023  | 13.0% | 67.6% | -5.0% | 0.3 | 333.2 |
| 2022-2024  | 0.0% | 67.6% | -22.0% | 0.3 | 390.7 |
| 2023-2025  | 19.0% | 50.6% | -22.0% | 0.2 | 399.9 |


**2. Recent Price Movement:**

* **Closing Price:** $170.58
* **Last Market Price:** $170.56
* **5-Day Moving Average:** $168.86
* **20-Day Moving Average:** $169.63
* **60-Day Moving Average:** $167.35

The price is slightly above the 5-day and 20-day moving averages, suggesting a recent short-term uptrend. However, it's relatively close to these averages, indicating potential consolidation or minor price fluctuations. The price is notably higher than the 60-day moving average, demonstrating a stronger upward trend over the longer term. The small price change ($0.08) from the previous close does not signify a significant upward or downward event.


**3. Technical Indicators & Expected Return:**

* **RSI:** 55.43 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 0.06 (Positive, indicating upward momentum)
* **Relative Divergence Change (20-day):** +10.5% (Short-term upward trend)
* **Market Risk Indicator (MRI):** 0.44 (Low to Medium Risk)
* **Expected Return (long-term):** 38.4% (Significant outperformance of S&P 500 expected over a 2+ year period)


**4. Recent Earnings Analysis:**

The provided earnings data shows relatively consistent revenue around $21 billion, with some minor fluctuation. EPS is also steadily increasing.  More data points and a longer time series are needed to fully analyze trends.  Note that the 2025-01-22 data is duplicated in the table.

| Date       | EPS  | Revenue       |
|------------|------|----------------|
| 2025-01-22 | 1.94 | $21.88B        |
| 2024-10-18 | 1.65 | $21.74B        |
| 2024-04-19 | 1.56 | $20.20B        |
| 2024-01-23 | 1.44 | $21.44B        |
| 2025-01-22 | 1.44 | $21.44B        |


**5. Financial Information:**

Both revenue and profit margins demonstrate stability and slight growth, indicating a healthy financial position. ROE also showcases variability but generally points to satisfactory profitability given the relatively stable Equity levels.  Further analysis of these trends requires a longer historical data set.

**Revenue and Profitability:**

| Quarter     | Revenue     | Profit Margin |
|-------------|-------------|---------------|
| 2024-12-31 | $21.88B     | 52.39%        |
| 2024-09-30 | $21.74B     | 52.06%        |
| 2024-06-30 | $20.53B     | 49.60%        |
| 2024-03-31 | $20.20B     | 51.20%        |
| 2023-12-31 | $21.44B     | 52.69%        |

**Capital and Profitability:**

| Quarter     | Equity      | ROE           |
|-------------|-------------|---------------|
| 2024-12-31 | $51.17B     | 9.05%         |
| 2024-09-30 | $51.84B     | 7.64%         |
| 2024-06-30 | $50.29B     | 6.24%         |
| 2024-03-31 | $50.06B     | 7.50%         |
| 2023-12-31 | $48.53B     | 7.15%         |


**6. Overall Analysis:**

PG shows strong historical performance, consistently outperforming the S&P 500.  While recent price movements suggest a relatively stable short-term trend, the positive PPO, RSI above neutral, and a strong relative divergence, coupled with a positive long-term expected return, suggest a potentially favorable outlook.  The company's financial statements exhibit stability and healthy profit margins.  However, a more comprehensive analysis would require a longer historical dataset and deeper dives into factors like debt, cash flow, and competitive landscape.  The relatively low market risk indicator adds to the positive assessment,  but it should be considered alongside other factors before making investment decisions.  The duplicated data point in the earnings report warrants clarification.
